# Claim table — McCullough / The Wellness Company Facebook Reel

| Claim / issue | Source-check status |
|---|---|
| A patient had heart damage and blood clots “exclusively” from Pfizer BNT162b2 and not SARS-CoV-2 infection. | Preserved as the Reel/caption claim. Needs the underlying case paper, patient history, lab methods, imaging, adjudication and independent review before being treated as proven. |
| Vaccine and spike protein were in the patient’s bloodstream 3.5 years after shots. | Preserved as a case-report claim. PBC did not recover the cited European Society of Medicine paper in this pass; ESM search page returned “No Results” for the query used. |
| This is the “first airtight proven case” that vaccine circulates in some people for a long time causing disease/damage. | A speaker interpretation. Even if a case report exists, one case does not prove frequency, general causation, or population-wide benefit-risk conclusions. |
| FDA Comirnaty records acknowledge myocarditis/pericarditis risk. | Supported. FDA package insert includes myocarditis/pericarditis warning language and says onset is typically in the first week after vaccination, highest observed risk in males 12–24. |
| Blood clots are a known COVID-vaccine safety issue. | Needs product separation. CDC/Canada identify rare clotting issues after vaccination; CDC’s specific TTS link is tied to J&J/Janssen, not Pfizer/Moderna mRNA in the same way. |
| “Observed harms far outweigh benefits.” | Not established by this source package. Official CDC/Canada pages still state vaccination protects against severe COVID-19 while monitoring rare adverse events. |